Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
REPORT: 340B HOSPITALS PRESCRIBE MEDICARE PART D DRUGS TO GREATER SHARES OF HISTORICALLY UNDERSERVED PATIENTS
-
340B HEALTH STATEMENT ON HRSA’S FINAL 340B ADMINISTRATIVE DISPUTE RESOLUTION (ADR) RULE
-
NEW FEDERAL LEGISLATION WOULD END DRUG COMPANY RESTRICTIONS ON 340B
-
STATEMENT ON SENATE 340B BIPARTISAN WORKING GROUP DISCUSSION DRAFT
-
FEDERAL COURT RULES HRSA IS UNLAWFULLY RESTRICTING PATIENTS WHO QUALIFY FOR 340B
-
STATEMENT ON CMS FINAL RULE FOR REMEDY OF UNLAWFUL 340B MEDICARE CUTS
-
25th DRUGMAKER TO IMPOSE 340B RESTRICTIONS ON HOSPITALS AND PHARMACY PARTNERS
-
HOUSE DRUG SHORTAGE BILL WOULD PROVIDE WINDFALL TO DRUGMAKERS WHILE HARMING 340B HOSPITALS
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
340B HEALTH RESPONDS TO SENATE REQUEST FOR INFORMATION ON 340B
-
HOSPITAL LEADER KAREN L. BOWLING ASSUMES CHAIR OF 340B HEALTH BOARD OF DIRECTORS
-
DRUGMAKERS THREATENING $8.4 BILLION OF 340B HOSPITAL FUNDING THROUGH RESTRICTIONS